Pasar al contenido principal

CARACTERIZACION FUNCIONAL Y ESTRUCTURAL DE LOS REORDENAMIENTOS KIF5B-RET

PID2020-117580RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PM534, an optimized target-protein interaction strategy through the colchicine site of tubulin

  • Lucena-Agell, Daniel
  • Guillén, María José
  • Matesanz, Ruth
  • Álvarez-Bernad, Beatriz
  • Hortigüela, Rafael
  • Avilés, Pablo
  • Martínez-Díez, Marta
  • Santamaría, Gema
  • Contreras, Julia
  • Plaza-Menacho, Iván
  • Giménez-Abián, Juan F.
  • Oliva, María A.
  • Cuevas, Carmen
  • Díaz, José Fernando
12 p.-4 fig.-2 tab., Targeting microtubules is the most effective wide-spectrum pharmacological strategy in antitumoral chemotherapy, and current research focuses on reducing main drawbacks: neurotoxicity and resistance. PM534 is a novel synthetic compound derived from the Structure–Activity-Relationship study on the natural molecule PM742, isolated from the sponge of the order Lithistida, family Theonellidae, genus Discodermia (du Bocage 1869). PM534 targets the entire colchicine binding domain of tubulin, covering four of the five centers of the pharmacophore model. Its nanomolar affinity and high retention time modulate a strikingly high antitumor activity that efficiently overrides two resistance mechanisms in cells (detoxification pumps and tubulin βIII isotype overexpression). Furthermore, PM534 induces significant inhibition of tumor growth in mouse xenograft models of human non-small cell lung cancer. Our results present PM534, a highly effective new compound in the preclinical evaluation that is currently in its first human Phase I clinical trial., This work was supported by Ministerio de Ciencia e Innovación (MICIN) and FEDER, PID2022–136765OB-I00 to J.F.D. and PID2021–123399OB-I00 to M.A.O., PID2020-117580RB-I00 to I.P-M., and Proyecto de Investigación en Neurociencia 2020 Fundación Tatiana Pérez de Guzmán el Bueno to J.F.D., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function

  • Cuesta-Hernández, Hipólito Nicolás
  • Contreras, Julia
  • Soriano-Maldonado, Pablo
  • Sánchez-Wandelmer, Jana
  • Yeung, Wayland
  • Martín-Hurtado, Ana
  • Muñoz, Inés G.
  • Kannan, Natarajan
  • Llimargas, Marta
  • Muñoz, Javier
  • Plaza-Menacho, Iván
Autophosphorylation controls the transition between discrete functional and conformational states in protein kinases, yet the structural and molecular determinants underlying this fundamental process remain unclear. Here we show that c-terminal Tyr 530 is a de facto c-Src autophosphorylation site with slow time-resolution kinetics and a strong intermolecular component. On the contrary, activation-loop Tyr 419 undergoes faster kinetics and a cis-to-trans phosphorylation switch that controls c-terminal Tyr 530 autophosphorylation, enzyme specificity, and strikingly, c-Src non-catalytic function as a substrate. In line with this, we visualize by X-ray crystallography a snapshot of Tyr 530 intermolecular autophosphorylation. In an asymmetric arrangement of both catalytic domains, a c-terminal palindromic phospho-motif flanking Tyr 530 on the substrate molecule engages the G-loop of the active kinase adopting a position ready for entry into the catalytic cleft. Perturbation of the phospho-motif accounts for c-Src dysfunction as indicated by viral and colorectal cancer (CRC)-associated c-terminal deleted variants. We show that c-terminal residues 531 to 536 are required for c-Src Tyr 530 autophosphorylation, and such a detrimental effect is caused by the substrate molecule inhibiting allosterically the active kinase. Our work reveals a crosstalk between the activation and c-terminal segments that control the allosteric interplay between substrate- and enzyme-acting kinases during autophosphorylation., The authors would like to thank Diamond Light Source for beamtime (beamline B21, proposal mx30297) and the ALBA Synchrotron Light Facility (XALOC-BL13 beamtime, proposal 2020094499) and their staff for assistance during data collection. We thank the Centro Nacional de Investigaciones Oncológicas (CNIO), which is supported by the Instituto de Salud Carlos III and recognized as a “Severo Ochoa” Centre of Excellence (ref. CEX2019-000891-S, awarded by MCIN/AEI/ 10.13039/5 01100011033) for core funding and supporting this study. This work was further supported by projects: grant PGC2018-098449-B-I00 (M.L.) by Spanish Ministerio de Ciencia e Innovación (MCIN), BFU2017-86710-R funded by MCIN/AEI /10.13039/501100011033 and ERDF “A way of making Europe”, PID2020-117580RB-I00 funded by MCIN/ AEI /10.13039/501100011033, RYC-2016-1938 funded by MCIN/AEI /10.13039/501100011033 and ESF “Investing in your future”, and a Marie Curie WHRI-ACADEMY International grant (number 608765) to I.P.-M. FP7-PEOPLE-2013-COFUND - Marie-Curie Action: “Co-funding of regional, National and International Programmes” International grant (number 608765) to I.P.-M. and BES-2017 (ref: EV-2015-0510-17-3) grant from Agencia Estatal de Investigación to I.P.-M. and H.N.C.-H., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000891-S)., Peer reviewed